A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer

INTRODUCTION. Bevacizumab is increasingly being tested with neoadjuvant regimens in patients with localized cancer, but its effects on metastasis and survival remain unknown. This study examines the long-term outcome of clinical stage II/III rectal cancer patients treated in a prospective phase II s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Willett, Christopher G., Duda, Dan G., Ancukiewicz, Marek, Shah, Mira, Czito, Brian G., Bentley, Rex, Poleski, Martin, Fujita, Hiroshi, Lauwers, Gregory Y., Carroll, Madeline, Tyler, Douglas, Mantyh, Christopher, Shellito, Paul, Chung, Daniel C., Clark, Jeffrey W., Jain, Rakesh K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2010
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3078712/
https://ncbi.nlm.nih.gov/pubmed/20667969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0030
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak